-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Polypid Says Positive Recommendation By DSMB To Continue Enrollment Of Phase 3 Shield II Trial Of D-Plex₁₀₀ To 800 Patients; Concurrent Private Placement Upto $41 Mln

Reuters·12/24/2024 00:26:12

Please log in to view news